Clinical Trials Logo

Filter by:
NCT ID: NCT00282789 Completed - Clinical trials for Dilated Cardiomyopathy

BiPAP for Cardiomyopathy With Central Sleep Apnea

Start date: June 2000
Phase: N/A
Study type: Interventional

We investigated whether treatment of central sleep apnea-hypopnea with bilevel positive airway pressure (BiPAP) in patients with idiopathic dilated cardiomyopathy (IDCM) would improve LV function.

NCT ID: NCT00281047 Recruiting - Helicobacter Pylori Clinical Trials

The Influence of FP-10 on the Eradication Rates of H. Pylori by a Triple Therapy

Start date: January 2006
Phase: Phase 2/Phase 3
Study type: Interventional

FP-10 is a food ingredient derived from milk casein. FP-10 can inhibit H. pylori to attach to the gastric epithelium. FP-10 has been made clear to decrease the intragastric urease activity (which is assumed to be produced by H. pylori) measured by the urea breath test. FP-10 can also detach H. pylori from gastric epithelium. We have hypothesized that FP-10 increases the eradication rates by a triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin.

NCT ID: NCT00281034 Completed - Stroke Clinical Trials

OASIS STUDY Outcome Assessment Using SF-36 v2 in Stroke Patient Study(OASIS STUDY)

Start date: September 2005
Phase: N/A
Study type: Observational

1. To survey the health-related quality of life using the SF-36v2 score of patients with chronic brain infarction in Japan 2. Chronic brain infarction in Japan is better than EU/USA

NCT ID: NCT00280969 Completed - HIV Infection Clinical Trials

Comparing the Effectiveness Between Ritonavir Boosted Atazanavir and Efavirenz for the First HIV Treatment

Start date: September 2005
Phase: Phase 3
Study type: Interventional

A selection study in treatment naive HIV patients to compare the virologic success rate of once daily antiretroviral treatment regimens at the 48th week with Epzicom(lamivudine and abacavir) plus efavirenz and Epzicom plus ritonavir boosted atazanavir. The superior regimen will be hired to the comparative study to the current first line regimen (tenofovir plus lamivudine plus efavirenz)

NCT ID: NCT00280696 Completed - Epilepsies, Partial Clinical Trials

A Double-blind Confirmatory Trial of Levetiracetam in Epilepsy Patients With Partial Onset Seizures

Start date: November 2005
Phase: Phase 3
Study type: Interventional

A double-blind, randomized, multicenter, placebo controlled 5 parallel groups, confirmatory trial to evaluated the efficacy and safety of levetiracetam used as adjunctive treatment in patients from 16 to 65 years with epilepsy suffering from partial onset seizures.

NCT ID: NCT00280475 Completed - Neoplasm Metastasis Clinical Trials

A Trial of Postoperative Whole Brain Radiation Therapy vs. Salvage Stereotactic Radiosurgery Therapy for Metastasis

Start date: January 2006
Phase: Phase 3
Study type: Interventional

The aim of this study is to evaluate non-inferiority of salvage stereotactic radiosurgery (SRS) in the patients who received surgical resection for brain metastases in comparison with postoperative whole brain radiation therapy (WBRT).

NCT ID: NCT00280410 Completed - Clinical trials for Lesions of the Liver

Study Investigating the Effect of E7337 on Tumor Like Lesions in Computed Tomography (CT) of the Liver

Start date: February 2006
Phase: Phase 2/Phase 3
Study type: Interventional

This is a multicenter, randomized, open-label study to investigate the superiority of the contrast enhancement effect of E7337 on tumor-like lesions in the Dynamic CT of the liver.

NCT ID: NCT00280397 Completed - Clinical trials for Cancer: Solid Tumors

An Open Label Phase I Dose Escalation Study of E7080 Administered to Patients With Solid Tumors

Start date: January 2006
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine the maximum tolerable dose (MTD) and the related effects of E7080 administered to patients with solid tumors that are resistant to approved existing anti-tumor therapies, or for which no appropriate treatment is available.

NCT ID: NCT00280384 Completed - Clinical trials for Spasmodic Torticollis

An Electrophysiological Study Of E2014 In Healthy Adult Male Japanese And Caucasian Subjects

Start date: January 2006
Phase: Phase 2
Study type: Interventional

To evaluate inter-ethnic similarity in pharmacodynamics between Japanese and Caucasian healthy adult male subjects by comparing electrophysiological reactions after administering E2014 to extensor digitorum brevis muscle (EDB).

NCT ID: NCT00276445 Terminated - Clinical trials for Allergic Conjunctivitis

Alleviation of Cedar Pollen Induced Allergic Symptoms by Orally Taken Superfine Beta-1,3-Glucan

Start date: January 2004
Phase: Phase 4
Study type: Interventional

Intravenous- injection of beta-1,3-glucan in human is known to induce T helper type 1 response, while oral uptake did not. It was examined whether superfine dispersed beta-1,3-glucan (SDG) contrived to absorbed by intestinal mucosa would alleviate allergic symptoms by per-oral ingestion